Chanock SJ, Gorlin JB. Granulocyte transfusions. Time for a second look. Infect Dis Clin North Am. 1996;10:327–43.
Article
CAS
PubMed
Google Scholar
Hubel K, Dale DC, Engert A, Liles WC. Use of G-CSF for granulocyte transfusion therapy. Cytokines Cell Mol Ther. 2000;6:89–95.
Article
CAS
PubMed
Google Scholar
Stroncek DF, Leitman SF. Granulocyte transfusions: a review. Immunohematology. 1998;14:101–8.
CAS
PubMed
Google Scholar
Huestis DW, Glasser L. The neutrophil in transfusion medicine. Transfusion. 1994;34:630–46.
Article
CAS
PubMed
Google Scholar
Vamvakas EC, Pineda AA. Determinants of the efficacy of prophylactic granulocyte transfusions: a meta-analysis. J Clin Apher. 1997;12:74–81.
Article
CAS
PubMed
Google Scholar
Dale DC, Price TH. Granulocyte transfusion therapy: a new era? Curr Opin Hematol. 2009;16:1–2.
Article
PubMed Central
PubMed
Google Scholar
Price TH. The use of G-CSF in normal neutrophil donors. Ann Med Interne (Paris). 2000;151:115–22.
CAS
Google Scholar
Price TH. The current prospects for neutrophil transfusions for the treatment of granulocytopenic infected patients. Transfus Med Rev. 2000;14:2–11.
Article
CAS
PubMed
Google Scholar
Takahata M, Fukuhara T, Shigematsu A, Onozawa M, Yamamoto Y, Miyake T, Maekawa I. Successful treatment with allogeneic peripheral blood stem cell transplantation and granulocyte transfusion for severe aplastic anemia with sinusitis. Transpl Infect Dis. 2006;8:44–8.
Article
CAS
PubMed
Google Scholar
Tsukada Y, Nagayama H, Mori T, Shimizu T, Sato N, Takayama N, Ishida A, Handa M, Ikeda Y, Okamoto S. Granulocyte transfusion as a treatment for enterococcal meningoencephalitis after allogeneic bone marrow transplantation from an unrelated donor. Bone Marrow Transplant. 2003;31:69–72.
Article
CAS
PubMed
Google Scholar
Di Mario A, Sica S, Salutari P, Ortu La Barbera E, Marra R, Leone G. Granulocyte colony-stimulating factor-primed leukocyte transfusions in candida tropicalis fungemia in neutropenic patients. Haematologica. 1997;82:362–3.
PubMed
Google Scholar
Safdar A, Rodriguez G, Zuniga J, Al Akhrass F, Pande A. Use of healthy-donor granulocyte transfusions to treat infections in neutropenic patients with myeloid or lymphoid neoplasms: experience in 74 patients treated with 373 granulocyte transfusions. Acta Haematol. 2014;131:50–8.
Article
PubMed Central
PubMed
Google Scholar
McCullough J, Clay M, Herr G, Smith J, Stroncek D. Effects of granulocyte-colony-stimulating factor on potential normal granulocyte donors. Transfusion. 1999;39:1136–40.
Article
CAS
PubMed
Google Scholar
Dale DC, Liles WC, Llewellyn C, Rodger E, Price TH. Neutrophil transfusions: kinetics and functions of neutrophils mobilized with granulocyte-colony-stimulating factor and dexamethasone. Transfusion. 1998;38:713–21.
Article
CAS
PubMed
Google Scholar
Quillen K, Yau YY, Leitman SF. The determinants of granulocyte yield in 1198 granulocyte concentrates collected from unrelated volunteer donors mobilized with dexamethasone and granulocyte-colony-stimulating factor: a 13-year experience. Transfusion. 2009;49:421–6.
Article
PubMed Central
PubMed
Google Scholar
Stroncek DF, Yau YY, Oblitas J, Leitman SF. Administration of G-CSF plus dexamethasone produces greater granulocyte concentrate yields while causing no more donor toxicity than G-CSF alone. Transfusion. 2001;41:1037–44.
Article
CAS
PubMed
Google Scholar
Heuft HG, Goudeva L, Sel S, Blasczyk R. Equivalent mobilization and collection of granulocytes for transfusion after administration of glycosylated G-CSF (3 microg/kg) plus dexamethasone versus glycosylated G-CSF (12 microg/kg) alone. Transfusion. 2002;42:928–34.
Article
CAS
PubMed
Google Scholar
Stroncek DF, Matthews CL, Follmann D, Leitman SF. Kinetics of G-CSF-induced granulocyte mobilization in healthy subjects: effects of route of administration and addition of dexamethasone. Transfusion. 2002;42:597–602.
Article
CAS
PubMed
Google Scholar
Worel N, Kurz M, Peters C, Hocker P. Serial granulocytapheresis under daily administration of rHuG-CSF: effects on peripheral blood counts, collection efficiency, and yield. Transfusion. 2001;41:390–5.
Article
CAS
PubMed
Google Scholar
de Haas M, Kerst JM, van der Schoot CE, Calafat J, Hack CE, Nuijens JH, Roos D, van Oers RH, von dem Borne AE. Granulocyte colony-stimulating factor administration to healthy volunteers: analysis of the immediate activating effects on circulating neutrophils. Blood. 1994;84:3885–94.
PubMed
Google Scholar
Stroncek DF, Jaszcz W, Herr GP, Clay ME, McCullough J. Expression of neutrophil antigens after 10 days of granulocyte-colony-stimulating factor. Transfusion. 1998;38:663–8.
Article
CAS
PubMed
Google Scholar
Rutella S, Pierelli L, Bonanno G, Sica S, Ameglio F, Capoluongo E, Mariotti A, Scambia G, d’Onofrio G, Leone G. Role for granulocyte colony-stimulating factor in the generation of human T regulatory type 1 cells. Blood. 2002;100:2562–71.
Article
CAS
PubMed
Google Scholar
Drewniak A, van Raam BJ, Geissler J, Tool AT, Mook OR, van den Berg TK, Baas F, Kuijpers TW. Changes in gene expression of granulocytes during in vivo granulocyte colony-stimulating factor/dexamethasone mobilization for transfusion purposes. Blood. 2009;113:5979–98.
Article
CAS
PubMed
Google Scholar
Drewniak A, Boelens JJ, Vrielink H, Tool AT, Bruin MC, van den Heuvel-Eibrink M, Ball L, van de Wetering MD, Roos D, Kuijpers TW. Granulocyte concentrates: prolonged functional capacity during storage in the presence of phenotypic changes. Haematologica. 2008;93:1058–67.
Article
PubMed
Google Scholar
Buzzeo MP, Yang J, Casella G, Reddy V. Hematopoietic stem cell mobilization with G-CSF induces innate inflammation yet suppresses adaptive immune gene expression as revealed by microarray analysis. Exp Hematol. 2007;35:1456–65.
Article
CAS
PubMed
Google Scholar
Massey E, Harding K, Kahan BC, Llewelyn C, Wynn R, Moppett J, Robinson SP, Green A, Lucas G, Sadani D, et al. The granulocytes in neutropenia 1 (GIN 1) study: a safety study of granulocytes collected from whole blood and stored in additive solution and plasma. Transfus Med. 2012;22:277–84.
Article
PubMed
Google Scholar
Ikemoto J, Yoshihara S, Fujioka T, Ohtsuka Y, Fujita N, Kokubunji A, Okamoto N, Ono J, Taniguchi K, Kaida K, et al. Impact of the mobilization regimen and the harvesting technique on the granulocyte yield in healthy donors for granulocyte transfusion therapy. Transfusion. 2012;52:2646–52.
Article
PubMed
Google Scholar
Cancelas JA, Padmanabhan A, Le T, Ambruso DR, Rugg N, Worsham DN, Pinkard SL, Graminske S, Buck J, Goldberg J, Bill J. Spectra Optia granulocyte apheresis collections result in higher collection efficiency of viable, functional neutrophils in a randomized, crossover, multicenter trial. Transfusion. 2014. doi:10.1111/trf.12907.
Google Scholar
Leitner GC, Kolovratova V, Horvath M, Worel N. Granulocyte collection using a novel apheresis system eases the procedure and provides concentrates of high quality. Transfusion. 2015;55:991–5.
Article
CAS
PubMed
Google Scholar
Thorausch K, Schulz M, Bialleck H, Luxembourg B, Seifried E, Bonig H. Granulocyte collections: comparison of two apheresis systems. Transfusion. 2013;53:3262–8.
Article
CAS
PubMed
Google Scholar
Chun H, Cipolone K, Procter J, Stroncek DF. Granulocyte storage and antigen stability. Transfusion. 1999;39:983–90.
Article
CAS
PubMed
Google Scholar
Lightfoot T, Gallelli J, Matsuo K, Kwon SW, Leitman SF, Stroncek DF. Evaluation of solutions for the storage of granulocyte colony-stimulating factor-mobilized granulocyte concentrates. Vox Sang. 2001;80:106–11.
Article
CAS
PubMed
Google Scholar
Lightfoot T, Leitman SF, Stroncek DF. Storage of G-CSF-mobilized granulocyte concentrates. Transfusion. 2000;40:1104–10.
Article
CAS
PubMed
Google Scholar
Leavey PJ, Thurman G, Ambruso DR. Functional characteristics of neutrophils collected and stored after administration of G-CSF. Transfusion. 2000;40:414–9.
Article
CAS
PubMed
Google Scholar
Hallahan AR, Shaw PJ, Rowell G, O’Connell A, Schell D, Gillis J. Improved outcomes of children with malignancy admitted to a pediatric intensive care unit. Crit Care Med. 2000;28:3718–21.
Article
CAS
PubMed
Google Scholar
Liang DC. The role of colony-stimulating factors and granulocyte transfusion in treatment options for neutropenia in children with cancer. Paediatr Drugs. 2003;5:673–84.
Article
PubMed
Google Scholar
Pham HP, Rogoza K, Stotler B, Duffy D, Parker-Jones S, Ginzburg Y, Bhatia M, Cairo M, Schwartz J. Granulocyte transfusion therapy in pediatric patients after hematopoietic stem cell transplantation: a 5-year single tertiary care center experience. J Pediatr Hematol Oncol. 2012;34:e332–6.
Article
PubMed
Google Scholar
Diaz R, Soundar E, Hartman SK, Dreyer Z, Teruya J, Hui SK. Granulocyte transfusions for children with infection and neutropenia or granulocyte dysfunction. Pediatr Hematol Oncol. 2014;31:425–34.
Article
PubMed
Google Scholar
Grigull L, Beilken A, Schmid H, Kirschner P, Sykora KW, Linderkamp C, Donnerstag F, Goudeva L, Heuft HG, Welte K. Secondary prophylaxis of invasive fungal infections with combination antifungal therapy and G-CSF-mobilized granulocyte transfusions in three children with hematological malignancies. Support Care Cancer. 2006;14:783–6.
Article
PubMed
Google Scholar
Atay D, Ozturk G, Akcay A, Yanasik M, Anak S, Devecioglu O. Effect and safety of granulocyte transfusions in pediatric patients with febrile neutropenia or defective granulocyte functions. J Pediatr Hematol Oncol. 2011;33:e220–5.
Article
PubMed
Google Scholar
Sachs UJ, Reiter A, Walter T, Bein G, Woessmann W. Safety and efficacy of therapeutic early onset granulocyte transfusions in pediatric patients with neutropenia and severe infections. Transfusion. 2006;46:1909–14.
Article
PubMed
Google Scholar
Seidel MG, Minkov M, Witt V, Matthes-Martin S, Potschger U, Worel N, Leitner G, Stary J, Gadner H, Peters C. Granulocyte transfusions in children and young adults: does the dose matter? J Pediatr Hematol Oncol. 2009;31:166–72.
Article
PubMed
Google Scholar
Cesaro S, Marson P, Messina C. Granulocyte-colony-stimulating factor-stimulated healthy donors and leukaemia risk. Vox Sang. 2003;85:125.
Article
CAS
PubMed
Google Scholar
van de Wetering MD, Weggelaar N, Offringa M, Caron HN, Kuijpers TW. Granulocyte transfusions in neutropaenic children: a systematic review of the literature. Eur J Cancer. 2007;43:2082–92.
Article
PubMed
Google Scholar
Peters C, Minkov M, Matthes-Martin S, Potschger U, Witt V, Mann G, Hocker P, Worel N, Stary J, Klingebiel T, Gadner H. Leucocyte transfusions from rhG-CSF or prednisolone stimulated donors for treatment of severe infections in immunocompromised neutropenic patients. Br J Haematol. 1999;106:689–96.
Article
CAS
PubMed
Google Scholar
Hester JP, Dignani MC, Anaissie EJ, Kantarjian HM, O’Brien S, Freireich EJ. Collection and transfusion of granulocyte concentrates from donors primed with granulocyte stimulating factor and response of myelosuppressed patients with established infection. J Clin Apher. 1995;10:188–93.
Article
CAS
PubMed
Google Scholar
Graham AS, Price TH, Brogan TV. Revisiting the use of granulocyte transfusions in pediatric oncology patients. J Pediatr Hematol Oncol. 2009;31:161–5.
Article
PubMed
Google Scholar
Stanworth SJ, Massey E, Hyde C, Brunskill S, Lucas G, Navarrete C, Marks DI. Granulocyte transfusions for treating infections in patients with neutropenia or neutrophil dysfunction. Cochrane Database Syst Rev. 2005;(3):CD005339.
Ikinciogullari A, Dogu F, Solaz N, Reisli I, Kemahli S, Cin S, Babacan E. Granulocyte transfusions in children with chronic granulomatous disease and invasive aspergillosis. Ther Apher Dial. 2005;9:137–41.
Article
PubMed
Google Scholar
Sharon RF, Bierings M, Vrielink H, Versluys B, Boelens JJ. Pre-emptive granulocyte transfusions enable allogeneic hematopoietic stem cell transplantation in pediatric patients with chronic infections. Bone Marrow Transplant. 2006;37:331–3.
Article
CAS
PubMed
Google Scholar
Lee JJ, Chung IJ, Park MR, Kook H, Hwang TJ, Ryang DW, Kim HJ. Clinical efficacy of granulocyte transfusion therapy in patients with neutropenia-related infections. Leukemia. 2001;15:203–7.
Article
CAS
PubMed
Google Scholar
Price TH, Bowden RA, Boeckh M, Bux J, Nelson K, Liles WC, Dale DC. Phase I/II trial of neutrophil transfusions from donors stimulated with G-CSF and dexamethasone for treatment of patients with infections in hematopoietic stem cell transplantation. Blood. 2000;95:3302–9.
CAS
PubMed
Google Scholar
Dignani MC, Anaissie EJ, Hester JP, O’Brien S, Vartivarian SE, Rex JH, Kantarjian H, Jendiroba DB, Lichtiger B, Andersson BS, Freireich EJ. Treatment of neutropenia-related fungal infections with granulocyte colony-stimulating factor-elicited white blood cell transfusions: a pilot study. Leukemia. 1997;11:1621–30.
Article
CAS
PubMed
Google Scholar
Cherif H, Axdorph U, Kalin M, Bjorkholm M. Clinical experience of granulocyte transfusion in the management of neutropenic patients with haematological malignancies and severe infection. Scand J Infect Dis. 2013;45:112–6.
Article
PubMed
Google Scholar
Mousset S, Hermann S, Klein SA, Bialleck H, Duchscherer M, Bomke B, Wassmann B, Bohme A, Hoelzer D, Martin H. Prophylactic and interventional granulocyte transfusions in patients with haematological malignancies and life-threatening infections during neutropenia. Ann Hematol. 2005;84:734–41.
Article
PubMed
Google Scholar
Price TH (2014) The RING study: a randomized controlled trial of GCSF-stimulated granulocytes in granulocytopenic patients. ASH Annual Meeting Abstracts 124:SCI-16-SCI-16.
Kadri SS, Remy KE, Strich JR, Gea-Banacloche J, Leitman SF. Role of granulocyte transfusions in invasive fusariosis: systematic review and single-center experience. Transfusion. 2015;55(9):2076–85.
Article
CAS
PubMed
Google Scholar
Wang H, Wu Y, Fu R, Qu W, Ruan E, Wang G, Liu H, Song J, Xing L, Guan J, et al. Granulocyte transfusion combined with granulocyte colony stimulating factor in severe infection patients with severe aplastic anemia: a single center experience from China. PLoS One. 2014;9:e88148.
Article
PubMed Central
PubMed
Google Scholar
Lee JJ, Song HC, Chung IJ, Bom HS, Cho D, Kim HJ. Clinical efficacy and prediction of response to granulocyte transfusion therapy for patients with neutropenia-related infections. Haematologica. 2004;89:632–3.
PubMed
Google Scholar
Hubel K, Carter RA, Liles WC, Dale DC, Price TH, Bowden RA, Rowley SD, Chauncey TR, Bensinger WI, Boeckh M. Granulocyte transfusion therapy for infections in candidates and recipients of HPC transplantation: a comparative analysis of feasibility and outcome for community donors versus related donors. Transfusion. 2002;42:1414–21.
Article
PubMed
Google Scholar
Metzendorf MI, Schulz M, Braun V. All information is not equal: using the literature databases PubMed and the Cochrane Library for identifying the evidence on granulocyte transfusion therapy. Transfus Med Hemother. 2014;41:364–74.
Article
PubMed Central
PubMed
Google Scholar
Massey E, Paulus U, Doree C, Stanworth S. Granulocyte transfusions for preventing infections in patients with neutropenia or neutrophil dysfunction. Cochrane Database Syst Rev. 2015;6:CD005341. doi:10.1002/14651858.CD005341.pub3.
Estcourt LJ, Stanworth S, Doree C, Blanco P, Hopewell S, Trivella M, Massey E. Granulocyte transfusions for preventing infections in people with neutropenia or neutrophil dysfunction. Cochrane Database Syst Rev. 2015;6:CD005341.
PubMed Central
PubMed
Google Scholar
Stroncek DF, Leonard K, Eiber G, Malech HL, Gallin JI, Leitman SF. Alloimmunization after granulocyte transfusions. Transfusion. 1996;36:1009–15.
Article
CAS
PubMed
Google Scholar
Heim KF, Fleisher TA, Stroncek DF, Holland SM, Gallin JI, Malech HL, Leitman SF. The relationship between alloimmunization and posttransfusion granulocyte survival: experience in a chronic granulomatous disease cohort. Transfusion. 2011;51:1154–62.
Article
PubMed Central
CAS
PubMed
Google Scholar
Mannoni P, Rodet M, Vernant JP, Brun B, Coquin-Radeau EI, Bracq C, Rochant H, Dreyfus B. Efficiency of prophylactic granulocyte transfusions in preventing infections in acute leukaemia. Rev Fr Transfus Immunohematol. 1979;22:503–18.
CAS
PubMed
Google Scholar
Gomez-Villagran JL, Torres-Gomez A, Gomez-Garcia P, Martinez-Guibelalde F, Velasco-Jimena F. A controlled trial of prophylactic granulocyte transfusions during induction chemotherapy for acute nonlymphoblastic leukemia. Cancer. 1984;54:734–8.
Article
CAS
PubMed
Google Scholar
Clift RA, Sanders JE, Thomas ED, Williams B, Buckner CD. Granulocyte transfusions for the prevention of infection in patients receiving bone-marrow transplants. N Engl J Med. 1978;298:1052–7.
Article
CAS
PubMed
Google Scholar
Anderlini P. Effects and safety of granulocyte colony-stimulating factor in healthy volunteers. Curr Opin Hematol. 2009;16:35–40.
Article
PubMed Central
CAS
PubMed
Google Scholar
Rutella S, Rumi C, Pierelli L, Morosetti R, Sica S, Bonanno G, Scambia G, Leone G. Granulocyte colony-stimulating factor perturbs lymphocyte mitochondrial function and inhibits cell cycle progression. Exp Hematol. 2000;28:612–25.
Article
CAS
PubMed
Google Scholar
Rutella S, Zavala F, Danese S, Kared H, Leone G. Granulocyte colony-stimulating factor: a novel mediator of T cell tolerance. J Immunol. 2005;175:7085–91.
Article
CAS
PubMed
Google Scholar
Rutella S, Rumi C, Testa U, Sica S, Teofili L, Martucci R, Peschle C, Leone G. Inhibition of lymphocyte blastogenic response in healthy donors treated with recombinant human granulocyte colony-stimulating factor (rhG-CSF): possible role of lactoferrin and interleukin-1 receptor antagonist. Bone Marrow Transplant. 1997;20:355–64.
Article
CAS
PubMed
Google Scholar
Shaw BE, Confer DL, Hwang W, Pulsipher MA. A review of the genetic and long-term effects of G-CSF injections in healthy donors: a reassuring lack of evidence for the development of haematological malignancies. Bone Marrow Transpl. 2015;50(3):334–40. doi:10.1038/bmt.2014.278.
Article
CAS
Google Scholar
Lyman GH, Dale DC. Long-term outcomes of myeloid growth factor treatment. J Natl Compr Canc Netw. 2011;9:945–52.
CAS
PubMed
Google Scholar
Avalos BR, Lazaryan A, Copelan EA. Can G-CSF cause leukemia in hematopoietic stem cell donors? Biol Blood Marrow Transplant. 2011;17:1739–46.
Article
CAS
PubMed
Google Scholar
Quillen K, Byrne P, Yau YY, Leitman SF. Ten-year follow-up of unrelated volunteer granulocyte donors who have received multiple cycles of granulocyte-colony-stimulating factor and dexamethasone. Transfusion. 2009;49:513–8.
Article
PubMed Central
PubMed
Google Scholar
Olnes MJ, Poon A, Miranda SJ, Pfannes L, Tucker Z, Loeliger K, Padilla-Nash H, Yau YY, Ried T, Leitman SF, et al. Effects of granulocyte-colony-stimulating factor on monosomy 7 aneuploidy in healthy hematopoietic stem cell and granulocyte donors. Transfusion. 2012;52:537–41.
Article
PubMed Central
CAS
PubMed
Google Scholar
Leitner GC, Faschingbauer M, Wenda S, Weigel G, Fischer G. Administration of recombinant human granulocyte-colony-stimulating factor does not induce long-lasting detectable epigenetic alterations in healthy donors. Transfusion. 2014;54:3121–6.
Article
CAS
PubMed
Google Scholar
Marmier-Savet C, Larosa F, Legrand F, Witz B, Michallet M, Ranta D, Louvat P, Puyraveau M, Raus N, Tavernier M, et al. Persistence of lymphocyte function perturbations after granulocyte-colony-stimulating factor mobilization and cytapheresis in normal peripheral blood stem cell donors. Transfusion. 2010;50:2676–85.
Article
PubMed
Google Scholar
De Silvestro G, Marson P, Cesaro S, Messina C. Legislative and ethical aspects of administering granulocyte colony-stimulating factor to normal donors. Haematologica. 2002;87:28–34.
PubMed
Google Scholar
Vetillard J, Drouet M, Neildez-Nguyen TM, Mestries JC, Mathieu J, Thierry D, Herodin F. Interleukine-8 acts as a strong peripheral blood granulocyte-recruiting agent rather than as a hematopoietic progenitor cell-mobilizing factor. J Hematother Stem Cell Res. 1999;8:365–79.
Article
CAS
PubMed
Google Scholar
Hubel K, Dale DC, Liles WC. Therapeutic use of cytokines to modulate phagocyte function for the treatment of infectious diseases: current status of granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor, macrophage colony-stimulating factor, and interferon-gamma. J Infect Dis. 2002;185:1490–501.
Article
CAS
PubMed
Google Scholar
Bodey GP, Anaissie E, Gutterman J, Vadhan-Raj S. Role of granulocyte-macrophage colony-stimulating factor as adjuvant treatment in neutropenic patients with bacterial and fungal infection. Eur J Clin Microbiol Infect Dis. 1994;13(Suppl 2):S18–22.
Article
PubMed
Google Scholar
Nemunaitis J, Meyers JD, Buckner CD, Shannon-Dorcy K, Mori M, Shulman H, Bianco JA, Higano CS, Groves E, Storb R, et al. Phase I trial of recombinant human macrophage colony-stimulating factor in patients with invasive fungal infections. Blood. 1991;78:907–13.
CAS
PubMed
Google Scholar
Nemunaitis J, Shannon-Dorcy K, Appelbaum FR, Meyers J, Owens A, Day R, Ando D, O’Neill C, Buckner D, Singer J. Long-term follow-up of patients with invasive fungal disease who received adjunctive therapy with recombinant human macrophage colony-stimulating factor. Blood. 1993;82:1422–7.
CAS
PubMed
Google Scholar
Gallin J, Malech H, Melnick D. A controlled trial of interferon γ to prevent infection in chronic granulomatous disease. The International Chronic Granulomatous Disease Cooperative Study Group. N Engl J Med. 1991;324:509–16.
Article
Google Scholar
Safdar A, Rodriguez GH, Lichtiger B, Dickey BF, Kontoyiannis DP, Freireich EJ, Shpall EJ, Raad II, Kantarjian HM, Champlin RE. Recombinant interferon γ1b immune enhancement in 20 patients with hematologic malignancies and systemic opportunistic infections treated with donor granulocyte transfusions. Cancer. 2006;106:2664–71.
Article
CAS
PubMed
Google Scholar
Li Y, Prasad A, Jia Y, Roy SG, Loison F, Mondal S, Kocjan P, Silberstein LE, Ding S, Luo HR. Pretreatment with phosphatase and tensin homolog deleted on chromosome 10 (PTEN) inhibitor SF1670 augments the efficacy of granulocyte transfusion in a clinically relevant mouse model. Blood. 2011;117:6702–13.
Article
PubMed Central
CAS
PubMed
Google Scholar
Rutella S, Pierelli L, Sica S, Serafini R, Chiusolo P, Paladini U, Leone F, Zini G, D’Onofrio G, Leone G, Piccirillo N. Efficacy of granulocyte transfusions for neutropenia-related infections: retrospective analysis of predictive factors. Cytotherapy. 2003;5:19–30.
Article
CAS
PubMed
Google Scholar
Kikuta A, Ohto H, Nemoto K, Mochizuki K, Sano H, Ito M, Suzuki H. Therapeutic transfusions of granulocytes collected by simple bag method for children with cancer and neutropenic infections: results of a single-centre pilot study. Vox Sang. 2006;91:70–6.
Article
CAS
PubMed
Google Scholar
Ozturkmen S, Altuntas F, Olcay L. Granulocyte transfusion therapy in paediatric patients with severe neutropenic infection. Transfus Apher Sci. 2013;48:381–5.
Article
PubMed
Google Scholar